ADAM17 and Stroke: Furthermore, our in vitro observations suggested that this stroke-driven increase in circulating sCD163 most likely originates from activated peripheral blood monocytes, as serum from ischemic stroke patients stimulated ADAM17-dependant sCD163 production in monocyte cultures generated from the peripheral blood of healthy individuals.